This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2022-2025.
Company Filing History:
Years Active: 2022-2025
Title: The Innovative Contributions of Allison P Lindberg
Introduction
Allison P Lindberg is a prominent inventor based in Arlington, MA (US). She has made significant contributions to the field of biopharmaceuticals, particularly in the development of bispecific antibodies. With a total of 2 patents to her name, her work is paving the way for new treatments in medicine.
Latest Patents
Lindberg's latest patents focus on bispecific antibodies against plasma kallikrein and Factor XII. These antibodies are designed to bind to plasma kallikrein (pKal) and Factor XII, providing methods for producing and utilizing these bi-specific antibodies in treating diseases or disorders associated with the contact system, such as hereditary angioedema or thrombosis. Her innovative approach holds promise for improving patient outcomes in these conditions.
Career Highlights
Allison P Lindberg is currently associated with Takeda Pharmaceutical Company Limited, where she continues to advance her research and development efforts. Her expertise in biopharmaceuticals has positioned her as a key player in the industry, contributing to the development of novel therapeutic solutions.
Collaborations
Throughout her career, Lindberg has collaborated with notable colleagues, including Jon A Kenniston and Andrew Nixon. These partnerships have enhanced her research capabilities and fostered innovation in her projects.
Conclusion
Allison P Lindberg's contributions to the field of biopharmaceuticals through her patents and collaborations highlight her role as an influential inventor. Her work continues to inspire advancements in medical treatments, showcasing the importance of innovation in healthcare.